These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 19183319)
1. Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study. Brouwers MC; Dekker JM; van Greevenbroek MM; van der Kallen CJ; Heine RJ; de Bruin TW; Stehouwer CD Diabet Med; 2008 Sep; 25(9):1121-4. PubMed ID: 19183319 [TBL] [Abstract][Full Text] [Related]
2. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained? Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518 [TBL] [Abstract][Full Text] [Related]
3. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224 [TBL] [Abstract][Full Text] [Related]
4. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia. ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424 [TBL] [Abstract][Full Text] [Related]
5. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118 [TBL] [Abstract][Full Text] [Related]
6. Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment. Vaverkova H; Frohlich J; Jackuliakova D; Novotny D Clin Biochem; 2005 Jun; 38(6):509-13. PubMed ID: 15885228 [TBL] [Abstract][Full Text] [Related]
7. Ezetimibe treatment of pediatric patients with hypercholesterolemia. Clauss S; Wai KM; Kavey RE; Kuehl K J Pediatr; 2009 Jun; 154(6):869-72. PubMed ID: 19230898 [TBL] [Abstract][Full Text] [Related]
8. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus. Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735 [TBL] [Abstract][Full Text] [Related]
11. Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus. van Greevenbroek MM; Vermeulen VM; Feskens EJ; Evelo CT; Kruijshoop M; Hoebee B; van der Kallen CJ; de Bruin TW Diabet Med; 2007 May; 24(5):498-504. PubMed ID: 17381501 [TBL] [Abstract][Full Text] [Related]
12. Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes. Sibal L; Neely RD; Jones A; Home PD Diabet Med; 2010 Jan; 27(1):37-45. PubMed ID: 20121887 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus. Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539 [TBL] [Abstract][Full Text] [Related]
14. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C; Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416 [TBL] [Abstract][Full Text] [Related]
16. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus. Garrido-Sánchez L; Cardona F; García-Fuentes E; Rojo-Martínez G; Gómez-Zumaquero JM; Picón MJ; Soriguer F; Tinahones FJ Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736 [TBL] [Abstract][Full Text] [Related]